Evidence map›Paper›PMID 33547114›Full record

ArticleBMJ case reports2021

Spontaneous tumour lysis syndrome in multiple myeloma with loss of 17p13.1, t(4;14) and monosomy 13.

Bushra Tbakhi, Sandrine Hanna, Yazan Samhouri, Deeraj Lingutla

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bushra TbakhiHematology/Oncology, University of Rochester, Rochester, New York, USA bushra_tbakhi@urmc.rochester.edu.ORCID http://orcid.org/0000-0003-1717-9396
Sandrine HannaInternal Medicine, Unity Hospital, Rochester, New York, USA.
Yazan SamhouriHematology/Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
Deeraj LingutlaInternal Medicine, Unity Hospital, Rochester, New York, USA.
Unity Hospital · USAllegheny General Hospital · USUniversity of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumour lysis syndrome (TLS) is a constellation of metabolic derangements caused by lysis of tumour cells. It is an oncological emergency that is considered a rare occurrence in multiple myeloma (MM) and usually occurs after patients have been treated with chemotherapy. We describe a very rare case of TLS occurring before the official diagnosis or treatment of MM. We report infrequent karyotype abnormalities, including loss of 17p13.1 (

Indexed as

Diagnosis, DifferentialDrug Therapy, CombinationFatal OutcomeHumansMaleMiddle AgedMonosomyMultiple MyelomaRenal DialysisTumor Lysis Syndromeacute renal failurecalcium and bonedialysishaematology (drugs and medicines)malignant and Benign haematology

Identifiers

PMID33547114
PMCPMC7871215
OpenAlexW3126553691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.